Stock Events

Stock Events

Pacific Edge Limited 

$0.07
8
-$0.11-61.43% Monday 20:00

Statistics

Day High
0.18
Day Low
0.18
52W High
0.23
52W Low
0.02
Volume
5,000
Avg. Volume
953
Mkt Cap
69.81M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

28FebExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

Financials

-136.9%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
25.52MRevenue
-34.93MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PFGTF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Exact Sciences
EXAS
Mkt Cap20.03B
Exact Sciences Corporation offers cancer screening and diagnostic tests, competing directly in the cancer diagnostics market similar to Pacific Edge.
Guardant Health
GH
Mkt Cap12.31B
Guardant Health provides liquid biopsy tests for cancer diagnostics, directly competing with Pacific Edge's cancer detection technologies.
Fulgent Genetics
FLGT
Mkt Cap525.3M
Fulgent Genetics, Inc. offers genetic testing to detect cancer, competing in the genomic and molecular diagnostic space like Pacific Edge.
Myriad Genetics
MYGN
Mkt Cap436.68M
Myriad Genetics, Inc. focuses on molecular diagnostic tests that assess the risk of developing cancer, similar to Pacific Edge's diagnostic products.
Qiagen NV
QGEN
Mkt Cap8.46B
QIAGEN N.V. provides sample to insight solutions including cancer diagnostics, competing in the same field as Pacific Edge.
NuCana
NCNA
Mkt Cap6.78M
NuCana plc develops technology to enhance chemotherapy agents, indirectly competing with Pacific Edge by offering alternative cancer treatment solutions.

About

Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up for patients with haematuria who have a low probability of bladder cancer; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a low risk of recurrence. In addition, the company is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Show more...
CEO
Dr. Peter Meintjes
Employees
114
Country
US
ISIN
NZPEBE0002S1

Listings

NZ
NZ
PEB.NZ
F
DE
CY3.F
AU
AU
PEB.AU
OTC Link
US
PFGTF

0 Comments

Share your thoughts

FAQ

What is Pacific Edge Limited stock price today?▼
The current price of PFGTF is $0.07 USD — it has decreased by -61.43% in the past 24 hours. Watch Pacific Edge Limited stock price performance more closely on the chart.
What is Pacific Edge Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pacific Edge Limited stocks are traded under the ticker PFGTF.
What is Pacific Edge Limited market cap?▼
Today Pacific Edge Limited has the market capitalization of 69.81M
What were Pacific Edge Limited earnings last quarter?▼
PFGTF earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pacific Edge Limited revenue for the last year?▼
Pacific Edge Limited revenue for the last year amounts to 25.52M USD.
What is Pacific Edge Limited net income for the last year?▼
PFGTF net income for the last year is -34.93M USD.
How many employees does Pacific Edge Limited have?▼
As of April 10, 2026, the company has 114 employees.
In which sector is Pacific Edge Limited located?▼
Pacific Edge Limited operates in the Health Care sector.
When did Pacific Edge Limited complete a stock split?▼
Pacific Edge Limited has not had any recent stock splits.
Where is Pacific Edge Limited headquartered?▼
Pacific Edge Limited is headquartered in Dunedin, US.